tiotropium bromide · Boehringer Ingelheim · NDA 021395
Spiriva
Earliest generic entry, as listed
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 021395 · 001 · RLD | powder, inhalation | EQ 0.018MG BASE/INH | open |
Expired or delisted (2)
- US 8022082 · — · 19 Jul 2026
- US 8022082 · product, use U-1186 · 19 Jan 2026